Interactive statistical monitoring to optimize review of potential clinical trial issues during study conduct

Leray, 2016, Epidemiology of multiple sclerosis, Rev. Neurol. (Paris), 172, 3, 10.1016/j.neurol.2015.10.006 Klein, 2013, Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties, mAbs, 5, 22, 10.4161/mabs.22771 Li, 2012, Volcano plots in analyzing differential expressions with mRNA microarrays, J. Bioinf. Comput. Biol., 10, 10.1142/S0219720012310038 Hoffelder, 2019, Equivalence analyses of dissolution profiles with the Mahalanobis distance, Biom. J., 61, 1120, 10.1002/bimj.201700257 Godavitarne, 2018, Understanding and interpreting funnel plots for the clinician, Br. J. Hosp. Med., 79, 578, 10.12968/hmed.2018.79.10.578 Buyse, 1999, For the ISCB Subcommittee on Fraud. The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials, Stat. Med., 18, 3435, 10.1002/(SICI)1097-0258(19991230)18:24<3435::AID-SIM365>3.0.CO;2-O Kirkwood, 2013, Application of methods for central statistical monitoring in clinical trials, Clin. Trials, 10, 783, 10.1177/1740774513494504 Venet, 2012, A statistical approach to central monitoring of data quality in clinical trials, Clin. Trials, 9, 705, 10.1177/1740774512447898